Rankings
▼
Calendar
BCYC Q4 2022 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$374M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
-15.5% YoY
Gross Profit
$3M
100.0% margin
Operating Income
-$32M
-1011.3% margin
Net Income
-$30M
-941.2% margin
EPS (Diluted)
$-1.01
QoQ Revenue Growth
+4.8%
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$32M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$411M
Total Liabilities
$140M
Stockholders' Equity
$271M
Cash & Equivalents
$339M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$4M
-15.5%
Gross Profit
$3M
$4M
-15.5%
Operating Income
-$32M
-$18M
-78.7%
Net Income
-$30M
-$18M
-66.2%
← FY 2022
All Quarters
Q1 2023 →